American Well (NYSE:AMWL) Given New $13.00 Price Target at TD Cowen

American Well (NYSE:AMWL) had its price objective boosted by research analysts at TD Cowen from $12.00 to $13.00 in a report released on Wednesday, Benzinga reports. The firm currently has a “hold” rating on the stock. TD Cowen‘s target price points to a potential upside of 4.37% from the company’s previous close.

A number of other research firms also recently weighed in on AMWL. Stifel Nicolaus upped their target price on American Well from $11.00 to $12.00 and gave the company a “hold” rating in a research report on Wednesday. Weiss Ratings restated a “sell (d-)” rating on shares of American Well in a research report on Thursday, October 15th. Needham & Company LLC reaffirmed a “hold” rating on shares of American Well in a research note on Wednesday, August 5th. Wells Fargo & Company upped their price objective on shares of American Well from $16.00 to $18.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Truist Financial set a $12.00 price objective on shares of American Well and gave the stock a “hold” rating in a research note on Thursday, August 13th. One equities research analyst has rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $12.30.

American Well Stock Down 2.2%

Shares of AMWL traded down $0.28 during mid-day trading on Wednesday, hitting $12.46. 113,947 shares of the company’s stock were exchanged, compared to its average volume of 101,139. American Well has a 52 week low of $3.71 and a 52 week high of $15.16. The stock’s 50-day simple moving average is $12.95 and its 200-day simple moving average is $8.99. The firm has a market cap of $206.15 million, a price-to-earnings ratio of -2.62 and a beta of 1.72.

American Well (NYSE:AMWL) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported ($0.67) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.78) by $0.11. The business had revenue of $48.99 million during the quarter, compared to analysts’ expectations of $47.28 million. American Well had a negative return on equity of 30.12% and a negative net margin of 35.75%. Analysts forecast that American Well will post -2.56 earnings per share for the current fiscal year.

Insider Activity at American Well

In other American Well news, insider Phyllis Gotlib sold 6,677 shares of the firm’s stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $13.00, for a total value of $86,801.00. Following the sale, the insider owned 142,504 shares of the company’s stock, valued at approximately $1,852,552. This trade represents a 4.48% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Dmitry Zamansky sold 8,442 shares of American Well stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $13.00, for a total value of $109,746.00. Following the completion of the transaction, the insider owned 224,178 shares in the company, valued at approximately $2,914,314. The trade was a 3.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 19,457 shares of company stock valued at $248,519. Company insiders own 12.84% of the company’s stock.

Institutional Trading of American Well

A hedge fund recently raised its position in American Well stock. Senvest Management LLC increased its position in shares of American Well Corporation (NYSE:AMWL) by 213.3% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,136,558 shares of the company’s stock after acquiring an additional 773,834 shares during the period. Senvest Management LLC owned about 6.87% of American Well worth $5,978,000 at the end of the most recent reporting period. Institutional investors own 56.05% of the company’s stock.

American Well News Roundup

Here are the key news stories impacting American Well this week:

• Positive Sentiment: Wells Fargo raised its price target to $18 from $16 and reiterated an Overweight rating, implying about 39% upside from the cited $12.93 share price. Wells Fargo recommendation
• Neutral Sentiment: Amwell reported Q3 revenue of $48.99 million, above analyst expectations of $47.28 million. Its $0.67 per-share loss was narrower than the year-ago loss of $1.74, but estimates differed: it beat MarketBeat’s consensus loss estimate of $0.78, while slightly missing Zacks’ estimate of $0.66. Q3 2026 results Zacks earnings analysis
• Negative Sentiment: Stifel raised its target to $12 from $11 but kept a Hold rating; its target was about 7% below the cited share price, offering a more cautious counterpoint to Wells Fargo’s upgrade. Stifel recommendation

American Well Company Profile

American Well, doing business as Amwell, is a digital healthcare company that provides technology and services for virtual care. Its platform connects patients with healthcare professionals through video and other digital channels, supporting services such as urgent care, behavioral health, primary care and specialty consultations.

Amwell primarily serves health systems, health plans, employers and other healthcare organizations. Its offerings include the Amwell Converge platform, which is designed to help organizations develop, manage and integrate digital care programs with existing clinical workflows and healthcare systems.

Founded in 2006 by brothers Ido and Roy Schoenberg, the company was formerly known as American Well and adopted the Amwell brand in 2020.